| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose and Multiple Doses With Titration of TAK-935 in Healthy Japanese Participants (NCT04461483) | Takeda | 2020-08-13 |
| A Study to Determine the Safety, Tolerability, and Pharmacokinetics of Lanadelumab Administered Intravenously in Healthy Adult Volunteer Participants (NCT04503603) | Takeda | 2020-08-10 |
| A Study of TAK-018 in Preventing the Recurrence of Crohn's Disease After Surgery (NCT03943446) | Takeda | 2020-08-04 |
| Wake and Sleep State Transitions on a Portable Electroencephalogram (EEG) Device in Narcolepsy Type 1 (NT1) and Healthy Participants (NCT04445129) | Takeda | 2020-08-03 |
| A Study of People With Multiple Myeloma (MM) in Portugal (CharisMMa-Portugal) (NCT04135963) | Takeda | 2020-07-31 |
| A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors (NCT04420884) | Takeda | 2020-07-22 |
| A Study of TAK-102 in Adult With Previously-Treated Solid Tumors (NCT04405778) | Takeda | 2020-07-10 |
| Study to Assess Absolute Bioavailability of TAK-935 (OV935) and to Characterize Mass Balance, Pharmacokinetics, Metabolism, and Excretion of [14C]TAK-935 (OV935) in Healthy Male Participants (NCT04992442) | Takeda | 2020-07-09 |
| A Study of TAK-951 in Healthy Adults (NCT04486950) | Takeda | 2020-07-07 |
| A Study to Evaluate the Effect of High-Fat Meal on TAK-788 Pharmacokinetics (PK) in Healthy Adult Participants (NCT04441255) | Takeda | 2020-07-01 |
| A Study of Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic Pouchitis (NCT04799496) | Takeda | 2020-06-10 |
| A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy (NCT04096560) | Takeda | 2020-05-27 |
| A Study of Ninlaro in Real World Clinical Practice in China (NCT04328662) | Takeda | 2020-05-18 |
| A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) (NCT04206605) | Takeda | 2020-05-04 |
| A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection (NCT04198363) | Takeda | 2020-04-30 |
| A Study for Post-Marketing Surveillance of Niraparib in the Treatment of Adult Participants for Approved Indications in South Korea (NCT04589039) | Takeda | 2020-03-16 |
| A Study of Dexlansoprazole Modified Release (MR) in Gastroesophageal Reflux Disease (GERD) Participants in the Russian Federation (NCT04311541) | Takeda | 2020-03-15 |
| Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease" (NCT04285983) | Takeda | 2020-03-01 |
| Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma" (NCT04213209) | Takeda | 2020-02-14 |
| A Study of TAK-079 in People With Generalized Myasthenia Gravis (NCT04159805) | Takeda | 2020-01-14 |
| TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations (NCT04129502) | Takeda | 2020-01-10 |
| A Study With [18F]MNI-1054 to Determine Lysine -Specific Demethylase 1A (LSD1) Brain Enzyme Occupancy of TAK-418 After Single-Dose Oral Administration in Healthy Participants (NCT04202497) | Takeda | 2019-12-18 |
| A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-123 After Intravenous Infusion in Japanese Healthy Adult Male Participants (NCT04155567) | Takeda | 2019-11-13 |
| Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose (NCT03999996) | Takeda | 2019-11-12 |
| Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula (NCT04075825) | Takeda | 2019-11-05 |
| A Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation (NCT03608501) | Takeda | 2019-09-30 |
| A Study of Usage of Brigatinib in the Treatment of Adult Participants for Approved Indications In South Korea (NCT04592523) | Takeda | 2019-09-05 |
| A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM) (NCT03984097) | Takeda | 2019-07-29 |
| A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems (NCT03814005) | Takeda | 2019-07-10 |
| Perianal Fistula (PAF) Validation and Burden of Illness Study (NCT03981939) | Takeda | 2019-07-02 |
| A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate, Midazolam, in Participants With ALK-Positive or ROS1-Positive Solid Tumors (NCT03420742) | Takeda | 2019-06-26 |
| A Study to Describe Treatment Patterns and Disease Control in Participants With cHL and sALCL in Routine Clinical Practice in the Russian Federation (NCT03942263) | Takeda | 2019-05-31 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Healthy Participants (NCT03933488) | Takeda | 2019-05-01 |
| A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer (NCT03596866) | Takeda | 2019-04-19 |
| Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) at the End of Shelf Life in Healthy Adults (NCT03771963) | Takeda | 2019-03-28 |
| A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After Surgery (NCT03827655) | Takeda | 2019-03-07 |
| A Study of TAK-951 in Healthy Adults (NCT05567393) | Takeda | 2019-03-07 |
| Phase 3 Study of Cx601 in Participants With Complex Perianal Fistulising Crohn's Disease (NCT03706456) | Takeda | 2019-03-06 |
| Post Marketing Surveillance Study for ADYNOVATE in South Korea (NCT03824522) | Takeda | 2019-02-25 |
| A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants (NCT03710486) | Takeda | 2019-02-19 |
| A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer (NCT03807778) | Takeda | 2019-02-04 |
| Special Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis] (NCT03824561) | Takeda | 2019-02-01 |
| A Bioequivalence (BE) Study of TAK-438 Orally Disintegrating (OD) Tablet (NCT03808493) | Takeda | 2019-01-30 |
| A Study to Compare the Bioavailability (BA) of Dexlansoprazole Delayed-release Capsules (NCT03801148) | Takeda | 2019-01-10 |
| Immunogenicity and Safety of Tetravalent Dengue Vaccine Candidate (TDV) in Flavivirus-Naïve and Dengue-Immune Adults (NCT03746015) | Takeda | 2018-12-28 |
| Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer (NCT03759587) | Takeda | 2018-12-28 |
| Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer (NCT03759600) | Takeda | 2018-12-26 |
| A Study to Describe Pain Intensity, Pain Relief and Safety of Neosaldina in the Treatment of Tension-type Headaches (TTH) in Healthy Participants (NCT03666858) | Takeda | 2018-12-20 |
| A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) (NCT03488030) | Takeda | 2018-12-12 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With Narcolepsy (NCT03748979) | Takeda | 2018-11-21 |
| Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease (NCT03738475) | Takeda | 2018-11-11 |
| Rasagiline Tablets Special Drug Use-Results Survey "Survey on Long-term Safety" (NCT03727139) | Takeda | 2018-11-01 |
| Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Untreated CD30-Positive Hodgkin's Lymphoma" (NCT03729609) | Takeda | 2018-11-01 |
| A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia (NCT03589326) | Takeda | 2018-10-04 |
| A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System (NCT03648372) | Takeda | 2018-10-01 |
| A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD) (NCT03668249) | Takeda | 2018-09-26 |
| A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY) (NCT03694275) | Takeda | 2018-09-10 |
| Multiple Myeloma (MM) Profile in Brazil: A Retrospective Observational Analysis (NCT03506386) | Takeda | 2018-08-09 |
| A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies (NCT03650452) | Takeda | 2018-08-08 |
| A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma (NCT03586973) | Takeda | 2018-08-06 |
| Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) (NCT03196427) | Takeda | 2018-07-30 |
| A Study to Determine Progression-free Survival (PFS) and Evaluate Participant Experience for Participants With Metastatic Anaplastic Lymphoma Kinase-positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) Treated With Anaplastic Lymphoma Kinase (ALK) Inhibitors (NCT03546894) | Takeda | 2018-07-23 |
| A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice (NCT03532932) | Takeda | 2018-07-20 |
| A Study of Soticlestat in Adults and Children With Rare Epilepsies (NCT03635073) | Takeda | 2018-07-19 |
| An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004 (NCT03596164) | Takeda | 2018-07-09 |
| A Study to Determine the Bioequivalence of Alogliptin and Pioglitazone When Administered as Individual Tablets and as Fixed-Dose Combination (FDC)-SYR-322-4833 BL Tablets to Healthy Russian Participants (NCT03501277) | Takeda | 2018-05-26 |
| Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Co-administered With an Hepatitis A Virus Vaccine (NCT03525119) | Takeda | 2018-05-16 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults (NCT03522506) | Takeda | 2018-05-09 |
| Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge (NCT03409796) | Takeda | 2018-04-24 |
| A Study of Niraparib as Single Agent in Participants With Advanced Solid Tumors (NCT03497429) | Takeda | 2018-04-05 |
| A Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated With Ixazomib Plus Lenalidomide and Dexamethasone (NCT03433001) | Takeda | 2018-04-02 |
| A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM) (NCT03439293) | Takeda | 2018-03-13 |
| A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy Participants (NCT03961308) | Takeda | 2018-03-12 |
| A Study to Evaluate the Bioequivalence (BE) and the Food Effect of TAK-438ASA Tablet (NCT03456960) | Takeda | 2018-03-08 |
| A Study to Determine the Pharmacokinetics (PK) of Single Intravenous (IV) Dose of Vedolizumab 300 Milligram (mg) in Healthy Adult Chinese Participants (NCT03329209) | Takeda | 2018-03-05 |
| Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults (NCT03342898) | Takeda | 2018-02-28 |
| A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy Participants (NCT03961295) | Takeda | 2018-02-22 |
| A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants (NCT03948581) | Takeda | 2018-02-21 |
| A Study to Evaluate the Efficacy and Safety of Ixazomib in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Initially Treated With an Injection of Proteasome Inhibitor-Based Therapy (NCT03416374) | Takeda | 2018-02-18 |
| A Bioequivalence Study of the Lu AA21004 20 mg and 2×10 mg Tablets (NCT03437564) | Takeda | 2018-02-16 |
| A Phase 1 Food Effect Study of Azilsartan (TAK-536) Pediatric Formulation (NCT03434977) | Takeda | 2018-02-14 |
| A Study to Assess the Effectiveness and Safety of Treatment With Vedolizumab in Adult Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real Life (NCT03378388) | Takeda | 2018-02-13 |
| Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue (NCT03423173) | Takeda | 2018-02-12 |
| A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants (NCT03949621) | Takeda | 2018-02-06 |
| Phase 2 Study of Brigatinib in Japanese Participants With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC) (NCT03410108) | Takeda | 2018-01-29 |
| Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease (NCT03486990) | Takeda | 2018-01-23 |
| A Phase 4 Post-marketing Study of Intramuscular Injections of BLB-750 in Healthy Adult Subjects (NCT03370289) | Takeda | 2018-01-12 |
| Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants (NCT03281577) | Takeda | 2018-01-02 |
| A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Renal Cell Carcinoma (NCT03339219) | Takeda | 2017-12-13 |
| Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease (NCT02559713) | Takeda | 2017-11-29 |
| Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) (NCT03268954) | Takeda | 2017-11-28 |
| A Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 Milligram (mg) and 60 mg Delayed-release Capsules in Healthy Chinese Participants (NCT03316976) | Takeda | 2017-11-22 |
| A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954 (NCT03296787) | Takeda | 2017-11-21 |
| B-CD30 + Hodgkin Lymphoma International Multi-center Retrospective Study of Treatment Practices and Outcomes (NCT03327571) | Takeda | 2017-11-21 |
| rVWF IN PROPHYLAXIS (NCT02973087) | Takeda | 2017-11-16 |
| Safety, Immunogenicity, and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy Participants (NCT03343626) | Takeda | 2017-11-13 |
| A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM) (NCT03173092) | Takeda | 2017-11-13 |
| A Study to Evaluate the Effect of Hepatic Impairment on the Single Dose Pharmacokinetics (PK) of Intravenous TAK-954 (NCT03277274) | Takeda | 2017-11-09 |
| Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) (NCT03138655) | Takeda | 2017-11-08 |
| Phase 1 TAK-925 Study in Healthy Adult and Elderly Volunteers and Participants With Narcolepsy (NCT03332784) | Takeda | 2017-11-04 |